Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation
Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation
复制标题
DOI:
10.1373/clinchem.2004.032698
复制
发表时间:
2005-03-01
影响因子:
9.3
通讯作者:
McNulty, H
中科院分区:
文献类型:
--
作者:
Holmes, VA;Wallace, JMW;McNulty, H
Background: In many countries, current recommendations are that women take a daily 400-mug folic acid supplement from before conception until the end of the 12th week of gestation for the prevention of neural tube defects. Low folate status is associated with an increased concentration of plasma total homocysteine (tHcy), a risk factor associated with pregnancy complications such as preeclampsia.Methods: In a longitudinal study, we determined tHcy and corresponding folate status in 101 pregnant women at 12, 20, and 35 weeks of gestation, in 35 nonpregnant controls sampled concurrently, and in a subgroup (n = 21 pregnant women and 19 nonpregnant controls) at 3 days postpartum.Results: Plasma tHcy was significantly lower throughout pregnancy compared with nonpregnant controls, with values lowest in the second trimester before increasing toward nonpregnant values in the third trimester. Importantly, mean tHcy concentrations were lower in pregnant women taking folic acid supplements than in those not, an effect that reached significance in the third trimester (5.45 vs 7.40 mumol/L; P